Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Tasocitinib shows promising pharmacokinetics in ocular tissues

Dec. 15, 2010

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Dec. 15, 2010

EyeGene's EGT-022 shows therapeutic potential in retinopathy model

Dec. 14, 2010

Nerviano discloses promising preclinical/clinical data on new oncolytic compounds

Dec. 14, 2010

Kinase inhibitors from Bayer show oncolytic activity alone and in combination

Dec. 14, 2010

Phase I and preclinical data presented on PD-0332991 in multiple myeloma

Dec. 14, 2010

Oncolytic agent S-110 shows promising preclinical results and advances into clinic

Dec. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...